Parameters | Control | Bilharzial bladder cancer patients | non-bilharzial bladder cancer patients | ANOVA P < |
---|---|---|---|---|
1. XO (μmol uric acid/min/ml) LSD | 0.3 ± 0.05 (2,3) | 2.77 ± 0.33 (1,3) | 1.58 ± 0.23 (1,2) | P < 0.0001 |
2. Fructosamine (μmol/L) LSD | 337.88 ± 34.4 (2,3) | 1145.27 ± 146.16 (1,3) | 742.3 ± 132.44 (1,2) | P < 0.0001 |
3. hydroxylproline (μg/ml) LSD | 23.35 ± 2.83 (2,3) | 78.56 ± 10.48 (1,3) | 46.06 ± 4.28 (1,2) | P < 0.0001 |
4. IgE (IU/ml) LSD | 44.37 ± 1.66 (2,3) | 301.49 ± 14.04 (1,3) | 269.0 ± 7.66 (1,2) | P < 0.0001 |
5. TNF-∝ (Pg/ml) LSD | 7.8 ± 0.22 (2,3) | 37.7 ± 1.61 (1,3) | 24.6 ± 0.84 (1,2) | P < 0.0001 |